Phase solubility behavior of hydrophilic polymer/cyclodextrin/lansoprazole ternary system studied at high polymer concentration and by response surface methodology

Pharmaceutical Development and Technology

Volumn 17, Issue 2, 2012, Pages 236-241

  Lu, Yi ^a   Tang, Ning ^a   Qi, Jianping ^a   Wu, Wei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Complexation efficiency; Cyclodextrin; PEG 6000; Phase solubility; PVP K30

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; CAVASOL; LANSOPRAZOLE; MACROGOL 6000; POLYMER; UNCLASSIFIED DRUG; YINGMEI;

ARTICLE; CHEMICAL INTERACTION; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); DRUG POTENTIATION; DRUG SOLUBILITY; PHASE SOLUBILITY; PRIORITY JOURNAL; RESPONSE SURFACE METHOD;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-INFECTIVE AGENTS; BETA-CYCLODEXTRINS; EXCIPIENTS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; PHARMACEUTIC AIDS; POLYETHYLENE GLYCOLS; POVIDONE; SOLUBILITY;

EID: 84863127604     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2010.531738     Document Type: Article

References (33)

1. Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 2007;59(7):645-666.
2. Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329(1-2):1-11.
3. Zheng Y, Haworth IS, Zuo Z, Chow MS, Chow AH. Physicochemical and structural characterization of quercetin-β-cyclodextrin complexes. J Pharm Sci 2005;94(5):1079-1089.
4. Loftsson T, Masson M, Sigurjónsdóttir JF. Enhanced complexation efficacy of cyclodextrins. In: Labandeira Torres JJ, Vila-Jato JL, editors. Proceedings of the 9th International Symposium on Cyclodextrins, Santiago de Compostela, Spain. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1998:257-260.
5. Patel AR, Vavia PR. Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation. J Incl Phenom Macro Chem 2006;56(1-2):247-251.
6. Loftsson T. Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water-soluble polymers. Pharmazie 1998;53(11):733-740.
7. Van Stam J, De Feyter S, De Schryver FC, EVans CH. 2-Naphthol complexation by β-cyclodextrin: Influence of added short linear alcohols. J Phys Chem 1996;100(51):19959-19966.
8. Yang H, Bohne C. Effect of amino acid co-inclusion on the complexation of pyrene with β-cyclodextrin. J Phys Chem 1996;100(34):14533-14539.
9. Skiba M, Nemati F, Puisieux F, Duchene D, Wouessidjewe D. Spontaneous formation of drug-containing amphiphilic β-cyclodextrin nanocapsules. Int J Pharm 1996;145(1-2):241-245.
10. Veiga MD, Ahsan F. Study of surfactants/β-cyclodextrin interactions over mequitazine dissolution. Drug Dev Ind Pharm 1997;23(7):721-725.
11. Jug M, Becirevic-Lacan M. Multicomponent complexes of piroxicam with cyclodextrins and hydroxypropyl methylcellulose. Drug Dev Ind Pharm 2004;30(10):1051-1060.
12. Ribeiro LSS, Ferreira DC, Veiga FJB. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Eur J Pharm Sci 2003;20(3):253-266.
13. Ribeiro L, Loftsson T, Ferreira D, Veiga F. Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether β-cyclodextrin binary and ternary complexes. Chem Pharm Bull 2003;51(8):914-922.
14. Valero M, Pérez-Revuelta BI, Rodríguez LJ. Effect of PVP K-25 on the formation of the naproxen:β-ciclodextrin complex. Int J Pharm 2003;253(1-2):97-110.
15. Vélaz I, Sánchez M, Martin C, Martínez- Ohárriz MC, Zornoza A. Interactions of naproxen with vinylpyrrolidone and β-cyclodextrin: A fluorimetric study. Int J Pharm 1997;153(2):211-217.
16. Sigurardóttir AM, Loftsson T. The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin. Int J Pharm 1995;126(1-2):73-78.
17. Valero M, Carrillo C. Effect of binary and ternary polyethyleneglycol and/or β-cyclodextrin complexes on the photochemical and photosensitizing properties of Naproxen. J Photochem Photobiol B Biol 2004;74(2-3):151-160.
18. Lahiani-Skiba M, Barbot C, Bounoure F, Joudieh S, Skiba M. Solubility and dissolution rate of progesterone-cyclodextrinpolymer systems. Drug Dev Ind Pharm 2006;32(9):1043-1058.
19. Valero M, Carrillo C, Rodríguez LJ. Ternary naproxen:β- cyclodextrin:polyethylene glycol complex formation. Int J Pharm 2003;265(1-2):141-149.
20. Hirlekar RS, Sonawane SN, Kadam VJ. Studies on the effect of water-soluble polymers on drug-cyclodextrin complex solubility. AAPS PharmSciTech 2009;10(3):858-863.
21. Zhang X, Wu D, Lai J, Lu Y, Yin Z, Wu W. Piroxicam/2-hydroxypropyl- β-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique. J Pharm Sci 2009;98(2):665-675.
22. Zhang X, Sun N, Wu B, Lu Y, Guan T, Wu W. Physical characterization of lansoprazole/PVP solid dispersion prepared by fluid-bed coating technique. Powd Tech 2008;182(3):480-485.
23. DellaGreca M, Iesce MR, Previtera L, Rubino M, Temussi F, Brigante M. Degradation of lansoprazole and omeprazole in the aquatic environment. Chemosphere 2006;63(7):1087-1093.
24. Lindenstruth K, Müller BW. W/O/W multiple emulsions with diclofenac sodium. Eur J Pharm Biopharm 2004;58(3):6216-27.
25. Sun N, Wei X, Wu B, Chen J, Lu Y, Wu W. Enhanced dissolution of silymarin/polyvinylpyrrolidone solid dispersion pellets prepared by a one-step fluid-bed coating technique. Powd Tech 2008;182(1):72-80.
26. Higuchi T, Connors KA. Phase-solubility techniques. Adv Anal Chem Instrum 1965;4:117-212.
27. Acarturk F, Kislal O, Celebi N. The effect of some natural polymers on the solubility and dissolution characteristics of nifedipine. Int J Pharm 1992;85(1-3):1-6.
28. Loftsson T, Fridriksdottir F, Gudmundsdottir TK. The effect of water-soluble polymers on aqueous solubility of drugs. Int J Pharm 1996;127(2):293-296.
29. Asbahr AC, Franco L, Barison A, Silva CW, Ferraz HG, Rodrigues LN. Binary and ternary inclusion complexes of finasteride in HPCD and polymers: Preparation and characterization. Bioorg Med Chem 2009;17(7):2718-2723.
30. Loftsson T, Hreinsdóttir D, Másson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm 2005;302(1-2):18-28.
31. Rekharsky MV, Inoue Y. Complexation thermodynamics of cyclodextrins. Chem Rev 1998;98(5):1875-1918.
32. Loftsson T, Frioriksdóttir H, Siguroardóttir AM, Stefánsson E. Drug-cyclodextrin-polymer ternary complexes. Eur J Pharm Sci 1996;4(Suppl. 1):S144.
33. Barillaro V, Dive G, Bertholet P, Evrard B, Delattre L, Frederich M, Ziémons E, Piel G. Theoretical and experimental investigations of organic acids/cyclodextrin complexes and their consequences upon the formation of miconazole/cyclodextrin/acid ternary inclusion complexes. Int J Pharm 2008;347(1-2):62-70.